Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma in Situ

Clinical trial condition

Carcinoma in Situ

Explore clinical trials studying Carcinoma in Situ. Study availability and eligibility vary by location and protocol.

304 public trials 54 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma in Situ trial results

Completed

Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy

NCT00146536

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +11 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

NCT00890994

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +16 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery

NCT02391194

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Moores UC San Diego Cancer Center La Jolla, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Stanford Hospitals and Clinics Stanford, California, United States

View Trial Details

Completed

Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer

NCT00896857

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Not specified

View Trial Details

Completed

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

NCT01060085

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +13 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

NCT00005886

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Comprehensive Cancer Centers of the Desert Palm Springs, California, United States

Loyola University Medical Center Maywood, Illinois, United States

View Trial Details

Completed

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

NCT00637481

Conditions: Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Breast Cancer, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

NCT01372644

Conditions: Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Atypical Lobular Hyperplasia (ALH) of Breast, +14 more
Locations: NYU School of Medicine New York, United States

View Trial Details

Completed

Molecular Breast Imaging in Women With Atypia and LCIS

NCT00620087

Conditions: Adenocarcinoma, Atypical Ductal Hyperplasia, Atypical Lobular Hyperplasia, +14 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

NCT00438659

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +18 more
Locations: Rush-Copley Cancer Care Center Aurora, Illinois, United States

St. Joseph Medical Center Bloomington, Illinois, United States

Graham Hospital Canton, Illinois, United States

Memorial Hospital Carthage, Illinois, United States

View all 189 locations

View Trial Details